Vivimed Labs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

63.28

86.55

105.02

113.34

112.93

Operating profit

-5.70

-18.24

-9.15

-0.07

28.36

Interest

22.44

18.05

21.53

18.00

21.24

Gross profit

-25.97

-36.06

-30.48

-17.01

9.85

EPS (Rs)

-4.07

-5.31

-5.09

-3.08

0.21

Other income

2.17

0.23

0.20

1.06

2.72

Stock adjustment

0.22

0.06

1.69

-1.20

3.86

Raw material

34.71

51.00

69.33

73.59

45.73

Power and fuel

-

-

-

-

-

Employee expenses

15.16

12.34

16.65

15.03

13.26

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

18.89

41.39

26.51

26.00

21.73

Provisions made

-

-

-

-

-

Depreciation

8.97

8.04

8.93

8.52

7.89

Taxation

-1.21

-0.05

2.82

-

0.23

Net profit / loss

-33.73

-44.04

-42.23

-25.52

1.72

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.58

16.58

16.58

16.58

16.58

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-9.01

-21.07

-8.71

-0.06

25.11

GPM (%)

-39.69

-41.55

-28.96

-14.87

8.51

NPM (%)

-51.54

-50.75

-40.13

-22.31

1.49